top of page

Your Strategic and Tactical Partner

Science

Emerging Biotech

Venture-backed sponsors approaching first-in-human
​
Pre-IND through Phase 1 strategy. We act as fractional senior pharmacology or regulatory lead, available to investors and the board, embedded in the science of the program.

Foundations and Academics

Standing scientific advisor and grant-review support for disease foundations and academic translational programs. Reduced rate structure for non-commercial work.

Strategy Development
and Implementation
​
​
 
 Our Services are customized to meet the specific needs of each individual client, with expertise in:
 

  • Pharmacology & Toxicology

  • ​Preclinical & Clinical Model Development

  • Abuse potential assessments and DEA scheduling

  • Translational platforms

  • Study and Trial Designs that Work

  • Regulatory Support ~ All Regions

  • NeuroPsychiatry and Psychology

  • Consult-to-Advisory Board

  • BioMarkers and Translational Medicine

  • Pharmacodynamics, Pharmaco- metrics, Dose-Prediction and Scaling

  • Ventures

​​

Mid- and Large-Cap Pharmaceuticals

Internal program reviews and second opinions
​
Independent senior counsel for internal go / no-go decisions, abuse-liability strategy, and CNS-specific program reviews. Engagements are usually scoped around a single decision point.

Investors and Boards

Independent scientific diligence engagements for venture, growth, and corporate development teams. We read the data, identify the questions the deck does not answer, and put our name on the memo.

Implementation Planning
bottom of page